2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-

Product Name: 2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-
CAS No.: 1799506-07-2
Chemical Name: 2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-
Synonyms: HaloPROTAC3;VH285-PEG4-C4-Cl;Halo PROTAC-3|||HaloPROTAC 3|||HaloPROTAC-3;(2S,4R)-N-(2-(2-(2-(2-((6- Chlorohexyl)oxy)ethoxy)ethoxy)ethoxy)-4-(4- methylthiazol-5-yl)benzyl)-4-hydroxy-1-((S)-3-methyl-2-(1- oxoisoindolin-2-yl)butanoyl)pyrrolidine-2-carboxamide;(2S,4R)-N-({2-[2-(2-{2-[(6-chlorohexyl)oxy]ethoxy}ethoxy)ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl}methyl)-4-hydroxy-1-[(2S)-3-methyl-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide;2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-
CBNumber: CB48344045
Molecular Formula: C41H55ClN4O8S
Formula Weight: 799.42
MOL File: 1799506-07-2.mol

More

Less

2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)- Property

Boiling point:: 952.2±65.0 °C(Predicted)
Density: 1.250±0.06 g/cm3(Predicted)
pka: 14.07±0.40(Predicted)
form: Viscous Liquid
color: Colorless to off-white

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H303May be harmfulif swallowed

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

More

Less

2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)- Chemical Properties,Usage,Production

Uses

VH285-PEG4-C4-Cl (HaloPROTAC 3) is a conjugate of ligands for E3 and 16-atom-length linker. The connector of linker is Halogen group. VH285-PEG4-C4-Cl incorporates the VH285 based VHL ligand and an alkyl/ether-based linker. VH285-PEG4-C4-Cl is a highly potent and efficacious degrader of GFP-HaloTag7 with a DC50 of 19 nM. VH285-PEG4-C4-Cl is able to induce 90 % degradation of GFP-Halotag at 625 nM. VH285-PEG4-C4-Cl binds to VHL with an IC50 of 0.54 μM[1].

IC 50

VHL

References

[1] Buckley DL, et al. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. ACS Chem Biol. 2015 Aug 21;10(8):1831-7. DOI:10.1021/acschembio.5b00442

2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)- Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)- Suppliers

China 30 United States 1 Global 31

Shanghai EFE Biological Technology Co., Ltd.

Tel: 021-65675885 18964387627
Fax: 021-65675885
Email: info@efebio.com
Country: China
ProdList: 9803
Advantage: 58

Shanghai Han-Xiang Chemical Co., Ltd.

Tel: 15971444841
Fax: 18327183813
Email: amber@biochempartner.com
Country: China
ProdList: 3061
Advantage: 58

Jilin Province Woda Biotechnology Co., Ltd.

Tel: 13504435624
Email: 1927928688@qq.com
Country: China
ProdList: 1623
Advantage: 58

TargetMol Chemicals Inc.

Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 32470
Advantage: 58

ShangHai ChuanQian Chemcial Technique Centre

Tel: 15869524721
Email: 3525679403@qq.com
Country: China
ProdList: 4899
Advantage: 58

cjbscvictory

Tel: 13348960310
Email: 3003867561@qq.com
Country: China
ProdList: 10503
Advantage: 58

Nantong Hi-Future Biotechnology Co., Ltd

Tel: 18051384581
Email: sales@chemhifuture.com
Country: China
ProdList: 2958
Advantage: 58

Wuhan Augda Biotechnology Co., Ltd

Tel: 15071299552
Fax: QQ:262933239
Email: 262933239@qq.com
Country: China
ProdList: 7089
Advantage: 58

Bide Pharmatech Ltd.

Tel: 400-1647117 13681763483
Email: product02@bidepharm.com
Country: China
ProdList: 59936
Advantage: 58

TargetMol Chemicals Inc.

Tel: 4008200310
Email: marketing@tsbiochem.com
Country: China
ProdList: 24964
Advantage: 58

1799506-07-2, 2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-Related Search:

2-Pyrrolidinecarboxamide, N-[[2-[2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]ethoxy]-4-(4-methyl-5-thiazolyl)phenyl]methyl]-1-[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-3-methyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-

HaloPROTAC3

(2S,4R)-N-(2-(2-(2-(2-((6- Chlorohexyl)oxy)ethoxy)ethoxy)ethoxy)-4-(4- methylthiazol-5-yl)benzyl)-4-hydroxy-1-((S)-3-methyl-2-(1- oxoisoindolin-2-yl)butanoyl)pyrrolidine-2-carboxamide

Halo PROTAC-3|||HaloPROTAC 3|||HaloPROTAC-3

(2S,4R)-N-({2-[2-(2-{2-[(6-chlorohexyl)oxy]ethoxy}ethoxy)ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl}methyl)-4-hydroxy-1-[(2S)-3-methyl-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide

VH285-PEG4-C4-Cl

1799506-07-2

C41H55ClN4O8S